Patents by Inventor Michael AARON

Michael AARON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170304312
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 26, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Publication number: 20170305931
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: July 11, 2017
    Publication date: October 26, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Peter Justin Mikochik, John Charles Murray, Xinjun Hou
  • Patent number: 9781599
    Abstract: A system is described for controlling an actuating unit that restricts physical access such as a motorized garage door actuator unit. The system comprises a mobile wireless communication device, an electro-mechanical access control security device, and a receiving unit controlling the electro-mechanical access control security device, the receiving unit paired with the mobile wireless communication device for receiving user input for activating the electro-mechanical access control security device via a peer-to-peer communication directly with the mobile wireless communication device, and a pre-authorization of communication of the receiving unit with the mobile wireless communication device, the mobile wireless communication device receiving the pre-authorization from a central security server.
    Type: Grant
    Filed: January 9, 2012
    Date of Patent: October 3, 2017
    Assignee: Delphian Systems, LLC
    Inventors: Gary L. Myers, Ashok Hirpara, John D. Veleris, Arkadiusz Zimny, Michael Aaron Cohen, Eugene Nakshin
  • Patent number: 9771379
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2, R3, R4 and X are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: September 26, 2017
    Assignee: PFIZER INC.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill
  • Patent number: 9767159
    Abstract: Methods, systems, and apparatus, including computer programs encoded on a computer storage medium, for providing ranked search results responsive to a query. In one aspect, a method includes receiving, from a user device, a query specifying an entity, determining two or more resources each of which provide media content related to the entity, for each of the resources, determining an effectiveness measure that is a measure of the effectiveness of the resource to present, to a user of the user device, the media content related to the entity, ranking the resources using, at least in part, the respective effectiveness measure, and providing, to the user device, a presentation of search results for the ranked resources.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: September 19, 2017
    Assignee: Google Inc.
    Inventors: Steve Chen, Sara Su, Michael Aaron Safyan, Jason B. Douglas, Samuel Shoji Fukujima Goto
  • Patent number: 9751895
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: September 5, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Peter Justin Mikochik, John Charles Murray, Xinjun Hou
  • Publication number: 20170249057
    Abstract: Examples disclosed herein provide executable code within a media file. One example method includes identifying, via a processor, a media file that is to include executable code; and inserting, via the processor, the executable code into a track of the media file, the executable code to be executed upon playback of media within the media file and, when executed, the executable code is to cause control of an environment of a host device playing back the media.
    Type: Application
    Filed: September 30, 2014
    Publication date: August 31, 2017
    Applicant: HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP
    Inventors: Michael AARON, Eli REVACH, Amos NESHER
  • Patent number: 9744173
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: August 29, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Patent number: 9745317
    Abstract: The present invention provides, in part, compounds of Formula (I): and pharmaceutically acceptable salts thereof; processes for the preparation of; intermediates used in the preparation of; and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), schizotypal personality disorder, cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), ADHD, Parkinson's disease, anxiety, and depression.
    Type: Grant
    Filed: April 14, 2015
    Date of Patent: August 29, 2017
    Assignee: Pfizer Inc.
    Inventors: David Lawrence Firman Gray, Lei Zhang, Michael Aaron Brodney, Jennifer Elizabeth Davoren, Ivan Viktorovich Efremov, Michael Eric Green, Steven Victor O'Neil, Bruce Nelsen Rogers
  • Publication number: 20170242916
    Abstract: According to an example, different types of data stored at a database may be identified. The identified data may be scored, where different types of data are scored according to different schemes. The scored data that is above a threshold may be selectively retained. The different schemes may relate to measuring a relevancy of the identified data for predicting behavior of a system.
    Type: Application
    Filed: September 29, 2014
    Publication date: August 24, 2017
    Applicant: HEWLETT PACKARD ENTERPRISE DEVELOPMENT LP
    Inventors: Eli REVACH, Michael AARON, Amos NESHER, Shahar TAL
  • Publication number: 20170229023
    Abstract: A method of communication link accessibility aware navigation is provided that includes querying a communication link accessibility map based on a location of interest provided by a path planner for a communication node. A communication link accessibility indicator is received representing a communication link characteristic associated with the location of interest in response to querying the communication link accessibility map. A communication link accessibility weight is determined based on a mission priority of maintaining a communication link of the communication node. The communication link accessibility weight is applied to the communication link accessibility indicator.
    Type: Application
    Filed: October 27, 2015
    Publication date: August 10, 2017
    Applicant: SIKORSKY AIRCRAFT CORPORATION
    Inventors: Michael Aaron Connor, George Nicholas Loussides, Harshad S. Sane
  • Publication number: 20170221071
    Abstract: An issue resolution platform is implemented on a computer system that communicates with user devices over a network.
    Type: Application
    Filed: January 31, 2016
    Publication date: August 3, 2017
    Inventor: Michael Aaron Eton York
  • Publication number: 20170182739
    Abstract: Disclosed herein are methods for making asymmetric laminate structures and methods for reducing bow in asymmetric laminate structures, the methods comprising differentially heating the laminate structures during lamination or differentially cooling the laminate structures after lamination. Also disclosed herein are methods for reducing bow in asymmetric laminate structures, the methods comprising subjecting at least one substrate in the laminate structure to asymmetric tempering or annealing prior to lamination. Further disclosed herein are laminate structures made according to such methods.
    Type: Application
    Filed: December 21, 2016
    Publication date: June 29, 2017
    Inventors: James Gregory Couillard, Michael Aaron McDonald, Paul George Rickerl
  • Patent number: 9691201
    Abstract: An encrypted security system and associated methods for controlling physical access. The system includes a security server configured to receive a request for authentication from a mobile device, the request comprising information identifying the mobile device and a physical access control device. The security server forwards an encryption message comprising a plurality of unique identifiers to the physical access control device via the mobile device. The physical access control device is configured to authenticate the plurality of unique identifiers in the encryption message and operate an access control mechanism.
    Type: Grant
    Filed: July 7, 2015
    Date of Patent: June 27, 2017
    Assignee: DELPHIAN SYSTEMS, LLC
    Inventors: Gary L. Myers, Ashok Hirpara, John D. Veleris, Arkadiusz Zimny, Michael Aaron Cohen, Eugene Nakshin
  • Publication number: 20170151252
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variable R1 is as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: February 8, 2017
    Publication date: June 1, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Elizabeth Mary Beck, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Gabriela Barreiro, Erik Alphie LaChapelle, Bruce Nelsen Rogers
  • Publication number: 20170146749
    Abstract: A portable device for attaching a connector to an optical fiber, the optical fiber having an end, the device comprising means for receiving the optical fiber at the end of the optical fiber; and a connector station for autonomously attaching the connector to the optical fiber.
    Type: Application
    Filed: October 28, 2016
    Publication date: May 25, 2017
    Inventors: Danny Willy August VERHEYDEN, David Donald ERDMAN, Michael GURRERI, Randall Bobby Paul, Jan WATTÉ, Robert Charles FLAIG, Alan Edward PLOTTS, Michael Aaron KADAR-KALLEN, Shelly Anne BUCHTER, Jan VANDENBROECK, Patrick BILLET, Stefano BERI, André Johannes Maria HILDERINK, Hernes JACOBS, Petrus Theodorus RUTGERS, Petrus Theodorus KRECHTING, Martijn Johannes WOLBERS, Walter MATTHEUS, Cristian-Radu RADULESCU, Paul VITS, Karel Johannes VAN ASSENBERGH, Pieter Cornelis Johan DE JAGER, Henk Jan Theodoor VAN DER POL
  • Patent number: 9611264
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Grant
    Filed: September 22, 2016
    Date of Patent: April 4, 2017
    Assignee: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Romelia del Carmen Salomon Ferrer
  • Publication number: 20170088547
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, wherein the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: September 22, 2016
    Publication date: March 30, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Romelia del Carmen Salomon Ferrer
  • Publication number: 20170088558
    Abstract: The present invention is directed to compounds, tautomers and pharmaceutically acceptable salts of the compounds which are disclosed, wherein the compounds have the structure of Formula I, and the variables R1, R2 and R3 are as defined in the specification. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.
    Type: Application
    Filed: September 22, 2016
    Publication date: March 30, 2017
    Applicant: Pfizer Inc.
    Inventors: Michael Aaron Brodney, Christopher Ryan Butler, Lei Zhang, Brian Thomas O'Neill, Patrick Robert Verhoest, Peter Justin Mikochik, John Charles Murray, Xinjun Hou
  • Patent number: D791121
    Type: Grant
    Filed: December 26, 2015
    Date of Patent: July 4, 2017
    Assignee: Intel Corporation
    Inventors: David M. Collins, Douglas Satzger, Michael Aaron Hyde